Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00037434

Ligand	Ligand name	Chain	PDB	Tanimoto
HV8	BENZYL-2-AMINO-PARAMETHOXY-BENZYLSTATINE	C	1A8G	0.75
HV7	1-METHYLAMINE-2-HYDROXY-4-METHOXY-BENZENE	C	1A8G	0.8
SHP	(4-HYDROXYMALTOSEPHENYL)GLYCINE	A	1DSR	0.71
K55	(2S)-2-{4-butoxy-3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]benzyl}butanoic acid	A,B	2ZNP	0.72
965	(3-{3-[[2-CHLORO-3-(TRIFLUOROMETHYL)BENZYL](2,2-DIPHENYLETHYL)AMINO]PROPOXY}PHENYL)ACETIC ACID	A,B,D	1PQ6	0.71
4MU	7-hydroxy-4-methyl-2H-chromen-2-one	A,B	3ETS	0.71
YZ9	7-HYDROXY-2-OXO-CHROMENE-3-CARBOXYLIC ACID ETHYL ESTER	A,B,C	1GCZ	0.71
CPB	2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY-8-(3-HYDROXY-1-METHYL-PIPERIDIN-4-YL)-4H-BENZOPYRAN-4-ONE	A	1E1Y	0.7
CPB	2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY-8-(3-HYDROXY-1-METHYL-PIPERIDIN-4-YL)-4H-BENZOPYRAN-4-ONE	A,B	3BLR	0.7
CPB	2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY-8-(3-HYDROXY-1-METHYL-PIPERIDIN-4-YL)-4H-BENZOPYRAN-4-ONE	A	1C8K	0.7
GNT	(-)-GALANTHAMINE	A	1DX6	0.7
GNT	(-)-GALANTHAMINE	A	1QTI	0.7
GNT	(-)-GALANTHAMINE	A,B,C,D,E	2PH9	0.7
GNT	(-)-GALANTHAMINE	A,B	1W76	0.7
GNT	(-)-GALANTHAMINE	A	1W6R	0.7
HA2	6-[{(2S)-2-AMINO-3-[4-(BENZYLOXY)PHENYL]PROPYL}(HYDROXY)AMINO]-6-OXOHEXANOIC ACID)	A	2VJ8	0.7
AAY	8-[2-((2S)-4-HYDROXY-1-{[5-(HYDROXYMETHYL)-6-METHOXY-2-NAPHTHYL]METHYL}-6-OXOPIPERIDIN-2-YL)ETHYL]-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL 2-METHYLBUTANOATE	A,B	1XDD	0.75
AB8	(1S,3R,8AS)-8-(2-{(4S,6S)-3-(4-HYDROXY-3-METHOXYBENZYL)-4-[2-(METHYLAMINO)-2-OXOETHYL]-2-OXO-1,3-OXAZINAN-6-YL}ETHYL)-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL (2R)-2-METHYLBUTANOATE	A,B	1XDG	0.72
AP1	{3-[3-(3,4-DIMETHOXY-PHENYL)-1-(1-{1-[2-(3,4,5-TRIMETHOXY-PHENYL)-BUTYRYL]-PIPERIDIN-2YL}-VINYLOXY)-PROPYL]-PHENOXY}-ACETIC ACID	A,B	1BL4	0.7
FLQ	N-[6-(ACETYLAMINO)HEXYL]-3',6'-DIHYDROXY-3-OXO-3H-SPIRO[2-BENZOFURAN-1,9'-XANTHENE]-6-CARBOXAMIDE	C	2FDC	0.73
4MP	1-(4-METHOXYBENZOYL)-2-PYRROLIDINONE	A,B	2AL5	0.71
E20	1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE	A	1EVE	0.7
MTJ	N,O-DIMETHYL-L-TYROSINE	A,B	1ATL	0.72
REN	(S)-reticuline	A	3FWA	0.73
REN	(S)-reticuline	A	3D2D	0.73
U03	4-HYDROXY-7-METHOXY-3-(1-PHENYL-PROPYL)-CHROMEN-2-ONE	A	3UPJ	0.74
PY9	4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol	A,B	3EKR	0.73
SLX	(13aS)-3,10-dimethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-2,9-diol	A	3FW9	0.73
296	(3R)-3-amino-2,2-difluoro-3-(4-methoxyphenyl)propanoic acid	A,B	2RJS	0.74
B1L	3-[(4-HYDROXYBENZOYL)AMINO]AZEPAN-4-YL 4-HYDROXYBENZOATE	A	1REJ	0.7
FDS	FLUORESCIN	H	4FAB	0.7
C01	(2S)-(4-ISOPROPYLPHENYL)[(2-METHYL-3-OXO-5,7-DIPROPYL-2,3-DIHYDRO-1,2-BENZISOXAZOL-6-YL)OXY]ACETATE	A	1ZEO	0.7
HXP	3,6-DIHYDROXY-XANTHENE-9-PROPIONIC ACID	A	1XAN	0.75
TMS	N-PROPYL-4-[(E)-2-(3,4,5-TRIMETHOXY-PHENYL)-VINYL]-BENZAMIDE	A,B	1X6W	0.74
AGG	TIROFIBAN	A,B	2VDM	0.71
HOM	7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN	C,D	1CJF	0.71
F1I	N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide	A	2ZJI	0.77
401	(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid	A,B	2ZNQ	0.74
TOL	TOLRESTAT	A	2PDL	0.71
TOL	TOLRESTAT	A	2FZD	0.71
TOL	TOLRESTAT	A	2FZB	0.71
TOL	TOLRESTAT	A	1AH3	0.71
TOL	TOLRESTAT	X	1ZUA	0.71
TOL	TOLRESTAT	A	1AE4	0.71
BVL	(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one	A	2ZBH	0.7
DRS	(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid	A,B	3BXS	0.71
AJA	(6AR,10AR)-3-(1,1-DIMETHYLHEPTYL)-1-HYDROXY-6,6-DIMETHYL-6A,7,10,10A-TETRAHYDRO-6H-BENZO[C]CHROMENE-9-CARBOXYLIC ACID	A,B,C,D	2OM9	0.71